Coloplast A/S - Asset Resilience Ratio

Latest as of December 2023: -0.07%

Coloplast A/S (COLO-B) has an Asset Resilience Ratio of -0.07% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Coloplast A/S total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Dkr-33.00 Million
≈ $-5.16 Million USD Cash + Short-term Investments

Total Assets

Dkr48.59 Billion
≈ $7.60 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2002–2023)

This chart shows how Coloplast A/S's Asset Resilience Ratio has changed over time. See Coloplast A/S (COLO-B) shareholders funds for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Coloplast A/S's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Coloplast A/S market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Dkr0.00 0%
Short-term Investments Dkr-33.00 Million -0.07%
Total Liquid Assets Dkr-33.00 Million -0.07%

Asset Resilience Insights

  • Limited Liquidity: Coloplast A/S maintains only -0.07% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Coloplast A/S Industry Peers by Asset Resilience Ratio

Compare Coloplast A/S's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Alcon AG
SW:ALC
Medical Instruments & Supplies 0.26%
iRay Technology Co Ltd
SHG:688301
Medical Instruments & Supplies 0.68%
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN
Medical Instruments & Supplies 29.19%
Jiangsu Nanfang Medical
SHG:603880
Medical Instruments & Supplies 2.27%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 6.36%
I.Ceram SA
PA:ALICR
Medical Instruments & Supplies -1.61%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 4.42%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 51.82%

Annual Asset Resilience Ratio for Coloplast A/S (2002–2023)

The table below shows the annual Asset Resilience Ratio data for Coloplast A/S.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-09-30 -0.08% Dkr-39.00 Million
≈ $-6.10 Million
Dkr48.16 Billion
≈ $7.53 Billion
-0.71pp
2022-09-30 0.63% Dkr219.00 Million
≈ $34.26 Million
Dkr34.96 Billion
≈ $5.47 Billion
-0.80pp
2021-09-30 1.43% Dkr226.00 Million
≈ $35.36 Million
Dkr15.84 Billion
≈ $2.48 Billion
-0.51pp
2020-09-30 1.94% Dkr262.00 Million
≈ $40.99 Million
Dkr13.50 Billion
≈ $2.11 Billion
-0.52pp
2019-09-30 2.46% Dkr313.00 Million
≈ $48.97 Million
Dkr12.73 Billion
≈ $1.99 Billion
-0.18pp
2018-09-30 2.63% Dkr310.00 Million
≈ $48.50 Million
Dkr11.77 Billion
≈ $1.84 Billion
+0.02pp
2017-09-30 2.61% Dkr315.00 Million
≈ $49.28 Million
Dkr12.05 Billion
≈ $1.89 Billion
-1.83pp
2016-09-30 4.44% Dkr489.00 Million
≈ $76.51 Million
Dkr11.01 Billion
≈ $1.72 Billion
-0.36pp
2015-09-30 4.80% Dkr519.00 Million
≈ $81.20 Million
Dkr10.82 Billion
≈ $1.69 Billion
-1.17pp
2014-09-30 5.96% Dkr619.00 Million
≈ $96.85 Million
Dkr10.38 Billion
≈ $1.62 Billion
+2.04pp
2013-09-30 3.92% Dkr367.00 Million
≈ $57.42 Million
Dkr9.36 Billion
≈ $1.47 Billion
-2.42pp
2012-09-30 6.34% Dkr645.00 Million
≈ $100.91 Million
Dkr10.18 Billion
≈ $1.59 Billion
+0.18pp
2011-09-30 6.16% Dkr568.00 Million
≈ $88.87 Million
Dkr9.22 Billion
≈ $1.44 Billion
+6.15pp
2010-09-30 0.01% Dkr1.00 Million
≈ $156.46K
Dkr7.77 Billion
≈ $1.22 Billion
+0.00pp
2009-09-30 0.01% Dkr1.00 Million
≈ $156.46K
Dkr7.96 Billion
≈ $1.25 Billion
-3.85pp
2003-09-30 3.86% Dkr207.00 Million
≈ $32.39 Million
Dkr5.36 Billion
≈ $838.61 Million
+3.84pp
2002-09-30 0.02% Dkr1.00 Million
≈ $156.46K
Dkr4.49 Billion
≈ $702.34 Million
--
pp = percentage points

About Coloplast A/S

CO:COLO-B Denmark Medical Instruments & Supplies
Market Cap
$13.07 Billion
Dkr83.53 Billion DKK
Market Cap Rank
#1805 Global
#11 in Denmark
Share Price
Dkr402.80
Change (1 day)
+2.26%
52-Week Range
Dkr393.90 - Dkr696.00
All Time High
Dkr1106.54
About

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, wh… Read more